Abstracts

Search by keyword or author name.

Showing 840 abstracts.

In Utero Exposure of Dolutegravir and Efavirenz Assessed via Hair Levels in IMPAACT 2010 Trial

Conference

CROI 2026

Study

IMPAACT 2010

Authors

Jillian Pintye, Hideaki Okochi, Tariro Chawana, Esaú João, Sherika Hanley, Linda Aurpibul, Chelsea Stotz, Katie McCarthy, Patrick Jean-Philippe, Nahida Chakhtoura, Sean Brummel, Jeremiah Momper, Lameck Chinula, Shahin Lockman, Monica Gandhi

Long-Acting Cabotegravir+Rilpivirine in Adolescents: IMPAACT 2017 Week 96 & End of Study Results

Conference

CROI 2026

Study

IMPAACT 2017

Authors

Aditya Gaur, Kristin Baltrusaitis, Edmund Capparelli, Elizabeth Lowenthal, Mark Marzinke, Herta Crauwels, Amy Cheung, Ellen Townley, John Moye, Michael Whitton, Gaerolwe Masheto, Sisinyana Ruth Mathiba, Barbara Heckman, Carolyn Bolton Moore, IMPAACT 2017 Team

Characterizing Immune Activation in HIV-Exposed but Uninfected Infants in the First Year of Life

Conference

CROI 2026

Study

P1025

Authors

Isabelle Roseto, Lori Silveria, Kaili Curtis, Jennifer Canniff, Adriana Weinberg, Christiana Smith

Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in young children 10 to <40 kg

Conference

CROI 2026

Study

IMPAACT 2036

Authors

Mo Archary, Jorge Pinto, Edmund Caparelli, Ed Acosta, Amy Cheung, Herta Crauwels, Ellen Townley, Jack Moye, Mark Giganti, Rachel Scheckter, Barb Heckman, Cristina Hofer, Mrinmayee Dhar, Sisinyana Ruth Mathiba, CRAYON/IMPAACT 2036 Study Team

Higher HIV viremia was associated with accelerated VRC01 clearance in infants receiving early ART, leading to lower antibody exposure and highlighting the need for optimal bNAb dosing strategies

Conference

CROI 2026

Study

IMPAACT 2008

Authors

Jia Chen Gan, Elizabeth J. McFarland, Camlin Tierney, Alka Khaitan, Deborah Persaud, Mark Cotton, Dwight Yin, Jack Moye, Hans Spiegel, Macpherson Mallewa, Anne Coletti, Charlotte Perlowski, Tisungane Mvalo, Diane Costello, Chelsea Stotz, Edmund Capparelli, IMPAACT 2008 Study Team

Broadly Neutralizing Antibodies in Oral Secretions After Administration to Newborns Exposed to HIV

Conference

CROI 2026

Study

P1112

Authors

Elizabeth J. McFarland, Edmund V. Capparelli, Mark J. Giganti, Kelly Seaton, Caroline Brackett, Charlotte Perlowski, Dwight E. Yin, Hans Spiegel, Jack Moye, Sai Majji, Paul A. Harding, Richard A. Koup, Georgia Tomaras, Coleen K. Cunningham, IMPAACT P1112 team

Neutralizing antibody, VRC01, PK and safety among infants initiating very early ART in IMPAACT P1115

Conference

CROI 2026

Study

P1115

Authors

Elizabeth J. McFarland, Edmund V. Capparelli, Madeline Abbott, Camlin Tierney, Charlotte Perlowski, Mutsawashe Bwakura-Dangarembizi, Tsungai Mhembere, Hazzie Mvula, Patrick Jean-Philippe, Jack Moye, Diane Costello, Sarah Wojcinski, Bob C. Lin, Ellen Chadwick, IMPAACT P1115 Team

Harnessing Proviruses to Define bNAb Sensitivity in Infants With In-Utero HIV-1 (IMPAACT P1115)

Conference

CROI 2026

Study

P1115

Authors

Soumia Bekka, Adit Dhummakupt, Sijy O’Dell, Emily Tourtellott, Bryan S. Nelson, Kimesh L. Naidoo, Bernadette Malunda, Mutsa Bwakura-Dangarembizi, Diane Costello, Dwight E. Yin, Sai Majji, Reda Rawi, Ellen G. Chadwick, Nicole Doria-Rose, Deborah Persaud

TORCH Infections as Risk Factor For Adverse Birth Outcomes Among HIV-Exposed Neonates in Uganda

Conference

CROI 2026

Study

1077BF

Authors

Patience Atuhaire, Mark Giganti, Flynn McMorrow, Maxensia Owor, Philippa Musoke, Mary Glenn Fowler, PROMISE 1077BF team

VERY EARLY ART +/- VRC01 FOR IN UTERO HIV-1: VIROLOGIC OUTCOMES AT 2 YEARS OF AGE IN IMPAACT P1115

Conference

CROI 2026

Study

P1115

Authors

Jennifer Jao, Madeline Abbott, Camlin Tierney, Tichaona Vhembo, Teacler Nematadzira, Lynda Stranix-Chabanda, Josphat Kosegei, Anne Coletti, Sarah Wojcinski, Cheryl Jennings, Dwight Yin, John Moye, Deborah Persaud, Ellen G. Chadwick, IMPAACT P1115 study team